A. Mignon

588 total citations
22 papers, 453 citations indexed

About

A. Mignon is a scholar working on Epidemiology, Experimental and Cognitive Psychology and Pharmacology. According to data from OpenAlex, A. Mignon has authored 22 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 7 papers in Experimental and Cognitive Psychology and 6 papers in Pharmacology. Recurrent topics in A. Mignon's work include Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (6 papers), Pneumonia and Respiratory Infections (6 papers) and Treatment of Major Depression (6 papers). A. Mignon is often cited by papers focused on Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (6 papers), Pneumonia and Respiratory Infections (6 papers) and Treatment of Major Depression (6 papers). A. Mignon collaborates with scholars based in Belgium, United States and France. A. Mignon's co-authors include S. Leyman, Benjamin Fischler, Wilfried Allaerts, Carl Denef, Marc Ansseau, Adelin Albert, Wim Robberecht, Peter Carmeliet, Pierre Fossion and Paul Linkowski and has published in prestigious journals such as PLoS ONE, Methods in enzymology on CD-ROM/Methods in enzymology and Anesthesiology.

In The Last Decade

A. Mignon

21 papers receiving 431 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Mignon Belgium 10 119 96 94 74 69 22 453
Jeff Daiter Canada 17 64 0.5× 72 0.8× 132 1.4× 326 4.4× 70 1.0× 28 749
Christine L. Mulgrew United States 8 63 0.5× 127 1.3× 38 0.4× 134 1.8× 92 1.3× 9 475
Shubh Mohan Singh India 15 38 0.3× 129 1.3× 44 0.5× 95 1.3× 136 2.0× 72 618
Pilar M. Sanjuan United States 11 112 0.9× 258 2.7× 67 0.7× 288 3.9× 69 1.0× 25 655
Walter Dorus United States 9 59 0.5× 77 0.8× 59 0.6× 181 2.4× 140 2.0× 17 447
Jessica Greenwood United States 12 39 0.3× 86 0.9× 45 0.5× 68 0.9× 98 1.4× 20 561
Ileana Pacheco‐Colón United States 12 47 0.4× 87 0.9× 216 2.3× 82 1.1× 79 1.1× 25 363
J Levine United States 14 50 0.4× 198 2.1× 77 0.8× 96 1.3× 379 5.5× 37 768
Chris Boardman United States 13 35 0.3× 99 1.0× 58 0.6× 257 3.5× 67 1.0× 18 600
Jennifer B. Zogg United States 9 119 1.0× 85 0.9× 30 0.3× 89 1.2× 96 1.4× 11 457

Countries citing papers authored by A. Mignon

Since Specialization
Citations

This map shows the geographic impact of A. Mignon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Mignon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Mignon more than expected).

Fields of papers citing papers by A. Mignon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Mignon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Mignon. The network helps show where A. Mignon may publish in the future.

Co-authorship network of co-authors of A. Mignon

This figure shows the co-authorship network connecting the top 25 collaborators of A. Mignon. A scholar is included among the top collaborators of A. Mignon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Mignon. A. Mignon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mignon, A., et al.. (2023). Cost-utility of 20-valent pneumococcal conjugate vaccine compared to no vaccination and recommended alternative vaccines among Belgian adults. Expert Review of Vaccines. 22(1). 1008–1021. 8 indexed citations
2.
Wilson, Michele, Cheryl McDade, Johnna Perdrizet, et al.. (2021). Validation of a Novel Forecasting Method for Estimating the Impact of Switching Pneumococcal Conjugate Programs: Evidence from Belgium. Infectious Diseases and Therapy. 10(3). 1765–1778. 6 indexed citations
3.
Peetermans, Willy, Jan Verhaegen, Lieven Annemans, et al.. (2018). Cost-effectiveness of PCV13 vaccination in Belgian adults aged 65-84 years at elevated risk of pneumococcal infection. PLoS ONE. 13(7). e0199427–e0199427. 8 indexed citations
4.
Braeye, Toon, A. Mignon, Denis Piérard, et al.. (2016). Capture-Recapture Estimators in Epidemiology with Applications to Pertussis and Pneumococcal Invasive Disease Surveillance. PLoS ONE. 11(8). e0159832–e0159832. 10 indexed citations
5.
6.
Flamaing, Johan, et al.. (2015). Pneumococcal lower respiratory tract infections in adults: an observational case-control study in primary care in Belgium. BMC Family Practice. 16(1). 25–25. 9 indexed citations
7.
Eede, Filip Van Den, Marc Ansseau, Adelin Albert, et al.. (2013). Prevalence and clinical characteristics of remission during treatment in generalized anxiety. International Journal of Psychiatry in Clinical Practice. 17(2). 90–97. 5 indexed citations
8.
Ansseau, Marc, et al.. (2009). Objective: remission of depression in primary care. European Neuropsychopharmacology. 19(3). 169–176. 22 indexed citations
9.
10.
Garnerin, Philippe, Vincent Piriou, Pascale Dewachter, et al.. (2007). Prévention des erreurs médicamenteuses en anesthésie. Recommandations. Annales Françaises d Anesthésie et de Réanimation. 26(3). 270–273. 13 indexed citations
11.
Ansseau, Marc, et al.. (2005). Prevalence and impact of generalized anxiety disorder and major depression in primary care in Belgium and Luxemburg: the GADIS study. European Psychiatry. 20(3). 229–235. 64 indexed citations
12.
Nayer, André, Michel Schittecatte, Jean-Luc Evrard, et al.. (2002). Venlafaxine compared with fluoxetine in outpatients with depression and concomitant anxiety. The International Journal of Neuropsychopharmacology. 5(2). 115–20. 63 indexed citations
13.
Zdanowicz, Nicolas, et al.. (2002). Efficacy and tolerance of venlafaxine in depressed patients switched from prior antidepressant treatment. Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)). 8(2). 63–68. 6 indexed citations
14.
Dufour, André, et al.. (2001). Clinical acceptability of venlafaxine extended release and paroxetine in outpatients treated for depression by general practitioners. European Neuropsychopharmacology. 11. S224–S225. 3 indexed citations
15.
Nayer, André, et al.. (2000). Symptom relief obtained with Venlafaxine versus fluoxetine in depressed patients with concomitant anxiety. European Neuropsychopharmacology. 10. 242–242. 1 indexed citations
16.
Mignon, A., et al.. (1999). Venlafaxine versus fluoxetine in the treatment of depressed patients with concomitant anxiety. European Neuropsychopharmacology. 9. 224–224. 4 indexed citations
17.
Mignon, A., et al.. (1994). TRANSCUTANEOUS CRANIAL ELECTRICAL STIMULATION DECREASES ISOFLURANE AND EARLY POSTOPERATIVE BUPRENORPHINE REQUIREMENTS AFTER ABDOMINAL SURGERY. Anesthesiology. 81(SUPPLEMENT). A218–A218. 1 indexed citations
18.
Dautzenberg, Bertrand, A. Mignon, Willy Rozenbaum, et al.. (1991). Rifabutin in combination with clofazimine, isoniazid and ethambutol in the treatment of AIDS patients with infections due to opportunist mycobacteria. Tubercle. 72(3). 168–175. 29 indexed citations
19.
Allaerts, Wilfried, A. Mignon, & Carl Denef. (1991). Selectivity of juxtaposition between cup-shaped lactotrophs and gonadotrophs from rat anterior pituitary in culture. Cell and Tissue Research. 263(2). 217–225. 33 indexed citations
20.
Denef, Carl, et al.. (1989). Cell-to-cell communication in peptide target cells of anterior pituitary. Methods in enzymology on CD-ROM/Methods in enzymology. 168. 47–72. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeff Daiter Breakdown of academic impact, for papers by Christine L. Mulgrew Breakdown of academic impact, for papers by Shubh Mohan Singh Breakdown of academic impact, for papers by Pilar M. Sanjuan Breakdown of academic impact, for papers by Walter Dorus Breakdown of academic impact, for papers by Jessica Greenwood Breakdown of academic impact, for papers by Ileana Pacheco‐Colón Breakdown of academic impact, for papers by J Levine Breakdown of academic impact, for papers by Chris Boardman Breakdown of academic impact, for papers by Jennifer B. Zogg
Rankless by CCL
2026